The document summarizes the results of several randomized controlled trials that compared different dental implant systems. The trials evaluated outcomes such as implant failure rates, marginal bone loss, and peri-implant tissue health. The studies generally found no statistically significant differences between major implant systems from companies like Straumann, Nobel Biocare, 3i, and others for factors like failure rates or bone loss over periods of up to 5 years.